Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Clinical trial NCT04345367 · COMPLETED
Trial details
- NCT number
- NCT04345367
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-11
- Primary completion
- 2021-07-13
- Enrollment
- 727
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.